How much does Semaglutide cost? Brand vs compounded

How much does Semaglutide cost?

Anywhere from roughly $150 a month for compounded versions to about $1,350 for brand Wegovy at list — and the honest answer is that “semaglutide” isn’t one price, because it isn’t one product. The same molecule ships as three brands (Ozempic, Wegovy, Rybelsus), each priced and covered differently, plus a separate, legally contested compounded market. Where you land depends on which of those you get and what your insurance does with it. Every figure here is a draft pending verification — always confirm current pricing.

The dominant question people actually mean by “semaglutide cost” is brand versus compounded — a four-figure FDA-approved product against a few-hundred-dollar copy that the FDA hasn’t reviewed. That trade sits at the center of this page. The rest walks each route: the brand prices, the compounded reality, and the cash-pay and insured paths in between.

Brand Semaglutide prices

Three brands, one molecule, three price tags. Novo Nordisk sells semaglutide as Ozempic and Rybelsus for type 2 diabetes and Wegovy for weight loss — and the sticker prices differ:

Almost nobody pays list. With commercial insurance that covers the drug, the manufacturer savings cards can drop copays dramatically — as low as ~$25/mo for Ozempic, $0–$25/mo for Wegovy, and ~$10/mo for Rybelsus (⚠ verify each). The catch, every time: those cards require commercial insurance and exclude government plans.

The one true cash program is Wegovy’s NovoCare self-pay route at roughly $499 a month (⚠ verify) — Ozempic and Rybelsus don’t have an equivalent, so uninsured patients on those brands are usually left with a discount card. Because each brand’s coverage and savings terms differ, the detailed math lives on the brand cost pages linked above.

Compounded Semaglutide cost

Compounded semaglutide is the reason “how much is semaglutide” has such a wide floor. Telehealth compounded plans have commonly run in the ~$150–$300/mo range (⚠ verify current market), often bundled with a provider visit — a fraction of brand list price. That gap is the entire appeal, and it’s worth understanding exactly what creates it.

It’s cheaper for three structural reasons: it isn’t the patented brand product, it skips the FDA-approval and manufacturing overhead that brand pricing carries, and it’s typically sold as a multi-dose vial drawn with a syringe rather than a fixed-dose pen. None of those savings come from the drug being equivalent — they come from it being a different, unreviewed thing.

The honest framing: a low price on a product whose contents aren’t verified isn’t automatically a bargain. If you’re weighing it, read the full compounded semaglutide breakdown first — where it stands legally, how to tell a licensed pharmacy from a grey-market seller, and the salt-form and dosing risks that don’t show up on the price tag.

Semaglutide cost without insurance

If you’re paying cash, don’t hand a brand prescription to a regular pharmacy expecting a deal — that’s the ~$970–$1,350 route. Here are the realistic cash-pay paths, ranked cheapest to priciest:

1. Compounded semaglutide (~$150–$300/mo, ⚠ verify) — the cheapest sticker, and the most caveated. Not FDA-reviewed, legally restricted since the shortage ended, quality varies by seller. Read the full picture before treating price as the deciding factor.
2. Wegovy self-pay via NovoCare (~$499/mo, ⚠ verify) — the cheapest FDA-approved brand route for weight loss, and the one cash program Novo Nordisk actually offers. No insurance billed, no prior authorization.
3. Pharmacy discount cards — GoodRx-style cards knock real money off brand semaglutide, and prices swing widely between pharmacies in the same zip code (⚠ verify current ballpark). Call at least three and quote the exact brand and strength.
4. Brand list price (~$970–$1,350/mo) — the number to avoid. Nobody paying cash should land here if any option above applies.

The cheapest realistic path for most uninsured people is either compounded (with eyes open to the trade-offs) or, for a verified brand product, Wegovy’s self-pay program. What you won’t find is a legitimate generic — semaglutide is patent-protected into the 2030s, so “generic semaglutide” is a marketing tell, not a deal. And FSA/HSA dollars apply to any of these prescription routes, trimming the effective price by your tax rate.

Semaglutide cost with insurance

With insurance, the single biggest variable is the label on your prescription. Plans treat semaglutide’s two indications very differently:

• Diabetes (Ozempic, Rybelsus) is widely covered. If you have type 2 diabetes, coverage is common and copays are often modest — sometimes single digits with a savings card stacked on top.
• Weight loss (Wegovy) is a coin flip at best. Many employer plans exclude weight-management drugs entirely, so a Wegovy prescription can be denied even when the identical molecule would be covered as Ozempic for a diabetic patient.

Either way, expect prior authorization: your prescriber documents your diagnosis, BMI, weight-related conditions, and sometimes a prior “lifestyle intervention” before the plan approves. Some plans add step therapy — try a cheaper drug first. It’s routine paperwork for clinics that prescribe GLP-1s, not a dead end.

If you’re denied, appeal. The denial letter states a reason; the counter-move is a letter of medical necessity from your prescriber addressing that exact reason. Plans overturn a meaningful share of appeals, and a failed internal appeal still leaves you an external review by an independent third party. Before you assume the worst, run your specific plan through the checker — coverage is genuinely plan-by-plan.

Ways to bring the cost down

The levers that actually move the monthly number, in rough order of impact:

1. Start with the cost calculator. Before committing to a route, run your brand, dose, and coverage through the GLP-1 cost calculator to see the realistic monthly total — it’s the fastest way to compare paths side by side.
2. Match the label to your diagnosis. If you have type 2 diabetes, the diabetes brands (Ozempic, Rybelsus) are far easier to get covered than Wegovy. That’s a conversation with your prescriber, not a trick — but it’s the difference between a $25 copay and a $1,350 denial.
3. Stack a savings card on commercial coverage. If your plan covers the drug and you have commercial insurance, the manufacturer cards drop copays to as low as $0–$25/mo (⚠ verify). Enrollment is free — Ozempic, Wegovy, and Rybelsus each have their own offer.
4. Use Wegovy self-pay if you’re uninsured and want brand. The ~$499/mo NovoCare program (⚠ verify) beats list by hundreds and keeps you on an FDA-approved product.
5. Appeal a denial. Persistence overturns more weight-loss denials than people expect — a medical-necessity letter targeting the stated reason is the tool.
6. Spend pre-tax dollars. FSA/HSA funds apply to copays and cash-pay purchases alike, an effective 20–35% discount depending on your bracket.
7. Understand the compounded trade-off before chasing the lowest price. It’s the cheapest sticker, but not for the reasons that make a drug a bargain.